Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Cytokine-cytokine receptor interaction
| Aldesleukin | 002 [6] 2 , 35, 49, 65, 96, 97 💬1. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||
2 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Cytokine-cytokine receptor interaction
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬2. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||
3 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Cytokine-cytokine receptor interaction
| Basiliximab | 002 [5] 2 , 50, 97, 222, 228 💬3. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||
4 | Cytokine-cytokine receptor interaction 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Cytokine-cytokine receptor interaction
| Daclizumab | 013 [8] 13, 56, 60, 65, 97, 107, 283, 284 💬4. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||
5 | Endocytosis 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Endocytosis
| Aldesleukin | 002 [6] 2 , 35, 49, 65, 96, 97 💬5. Endocytosis
|
||||||||||||||||||||||||||||||||||||
6 | Endocytosis 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Endocytosis
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬6. Endocytosis
|
||||||||||||||||||||||||||||||||||||
7 | Endocytosis 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Endocytosis
| Basiliximab | 002 [5] 2 , 50, 97, 222, 228 💬7. Endocytosis
|
||||||||||||||||||||||||||||||||||||
8 | Endocytosis 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Endocytosis
| Daclizumab | 013 [8] 13, 56, 60, 65, 97, 107, 283, 284 💬8. Endocytosis
|
||||||||||||||||||||||||||||||||||||
9 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Hematopoietic cell lineage
| Aldesleukin | 002 [6] 2 , 35, 49, 65, 96, 97 💬9. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||
10 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Hematopoietic cell lineage
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬10. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||
11 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Hematopoietic cell lineage
| Basiliximab | 002 [5] 2 , 50, 97, 222, 228 💬11. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||
12 | Hematopoietic cell lineage 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Hematopoietic cell lineage
| Daclizumab | 013 [8] 13, 56, 60, 65, 97, 107, 283, 284 💬12. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||
13 | Human T-cell leukemia virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Human T-cell leukemia virus 1 infection
| Aldesleukin | 002 [6] 2 , 35, 49, 65, 96, 97 💬13. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||
14 | Human T-cell leukemia virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Human T-cell leukemia virus 1 infection
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬14. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||
15 | Human T-cell leukemia virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Human T-cell leukemia virus 1 infection
| Basiliximab | 002 [5] 2 , 50, 97, 222, 228 💬15. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||
16 | Human T-cell leukemia virus 1 infection 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Human T-cell leukemia virus 1 infection
| Daclizumab | 013 [8] 13, 56, 60, 65, 97, 107, 283, 284 💬16. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||
17 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬JAK-STAT signaling pathway
| Aldesleukin | 002 [6] 2 , 35, 49, 65, 96, 97 💬17. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||
18 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬JAK-STAT signaling pathway
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬18. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||
19 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬JAK-STAT signaling pathway
| Basiliximab | 002 [5] 2 , 50, 97, 222, 228 💬19. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||
20 | JAK-STAT signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬JAK-STAT signaling pathway
| Daclizumab | 013 [8] 13, 56, 60, 65, 97, 107, 283, 284 💬20. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||
21 | Measles 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Measles
| Aldesleukin | 002 [6] 2 , 35, 49, 65, 96, 97 💬21. Measles
|
||||||||||||||||||||||||||||||||||||
22 | Measles 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Measles
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬22. Measles
|
||||||||||||||||||||||||||||||||||||
23 | Measles 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Measles
| Basiliximab | 002 [5] 2 , 50, 97, 222, 228 💬23. Measles
|
||||||||||||||||||||||||||||||||||||
24 | Measles 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Measles
| Daclizumab | 013 [8] 13, 56, 60, 65, 97, 107, 283, 284 💬24. Measles
|
||||||||||||||||||||||||||||||||||||
25 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Pathways in cancer
| Aldesleukin | 002 [6] 2 , 35, 49, 65, 96, 97 💬25. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||
26 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Pathways in cancer
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬26. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||
27 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Pathways in cancer
| Basiliximab | 002 [5] 2 , 50, 97, 222, 228 💬27. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||
28 | Pathways in cancer 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Pathways in cancer
| Daclizumab | 013 [8] 13, 56, 60, 65, 97, 107, 283, 284 💬28. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||
29 | PI3K-Akt signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬PI3K-Akt signaling pathway
| Aldesleukin | 002 [6] 2 , 35, 49, 65, 96, 97 💬29. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||
30 | PI3K-Akt signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬PI3K-Akt signaling pathway
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬30. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||
31 | PI3K-Akt signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬PI3K-Akt signaling pathway
| Basiliximab | 002 [5] 2 , 50, 97, 222, 228 💬31. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||
32 | PI3K-Akt signaling pathway 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬PI3K-Akt signaling pathway
| Daclizumab | 013 [8] 13, 56, 60, 65, 97, 107, 283, 284 💬32. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||
33 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Th1 and Th2 cell differentiation
| Aldesleukin | 002 [6] 2 , 35, 49, 65, 96, 97 💬33. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||
34 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Th1 and Th2 cell differentiation
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬34. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||
35 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Th1 and Th2 cell differentiation
| Basiliximab | 002 [5] 2 , 50, 97, 222, 228 💬35. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||
36 | Th1 and Th2 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Th1 and Th2 cell differentiation
| Daclizumab | 013 [8] 13, 56, 60, 65, 97, 107, 283, 284 💬36. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||
37 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Th17 cell differentiation
| Aldesleukin | 002 [6] 2 , 35, 49, 65, 96, 97 💬37. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||
38 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Th17 cell differentiation
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬38. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||
39 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Th17 cell differentiation
| Basiliximab | 002 [5] 2 , 50, 97, 222, 228 💬39. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||
40 | Th17 cell differentiation 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Th17 cell differentiation
| Daclizumab | 013 [8] 13, 56, 60, 65, 97, 107, 283, 284 💬40. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||
41 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Aldesleukin Aldesleukin 💬Viral protein interaction with cytokine and cytokine receptor
| Aldesleukin | 002 [6] 2 , 35, 49, 65, 96, 97 💬41. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||
42 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Viral protein interaction with cytokine and cytokine receptor
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬42. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||
43 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Basiliximab Basiliximab 💬Viral protein interaction with cytokine and cytokine receptor
| Basiliximab | 002 [5] 2 , 50, 97, 222, 228 💬43. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||
44 | Viral protein interaction with cytokine and cytokine receptor 💬 1 gene, 4 drugs (DrugBank) and 21 diseases |
IL2RA [1] IL2RA 💬Cytokine-cytokine receptor interaction
|
Daclizumab Daclizumab 💬Viral protein interaction with cytokine and cytokine receptor
| Daclizumab | 013 [8] 13, 56, 60, 65, 97, 107, 283, 284 💬44. Viral protein interaction with cytokine and cytokine receptor
|
Cytokine-cytokine receptor interaction
1 gene, 4 drugs (DrugBank) and 21 diseases
Endocytosis
1 gene, 4 drugs (DrugBank) and 21 diseases
Hematopoietic cell lineage
1 gene, 4 drugs (DrugBank) and 21 diseases
Human T-cell leukemia virus 1 infection
1 gene, 4 drugs (DrugBank) and 21 diseases
JAK-STAT signaling pathway
1 gene, 4 drugs (DrugBank) and 21 diseases
Measles
1 gene, 4 drugs (DrugBank) and 21 diseases
Pathways in cancer
1 gene, 4 drugs (DrugBank) and 21 diseases
PI3K-Akt signaling pathway
1 gene, 4 drugs (DrugBank) and 21 diseases
Th1 and Th2 cell differentiation
1 gene, 4 drugs (DrugBank) and 21 diseases
Th17 cell differentiation
1 gene, 4 drugs (DrugBank) and 21 diseases
Viral protein interaction with cytokine and cytokine receptor
1 gene, 4 drugs (DrugBank) and 21 diseases